Found: 9
Select item for more details and to access through your institution.
Enhancement of Humoral and Cellular Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 by a Third Dose of BNT162b2 Vaccine in Japanese Healthcare Workers.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Persistence of Robust Humoral Immune Response in Coronavirus Disease 2019 Convalescent Individuals Over 12 Months After Infection.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 2, p. 1, doi. 10.1093/ofid/ofab626
- By:
- Publication type:
- Article
Sustained Neutralizing Antibodies 6 Months Following Infection in 376 Japanese COVID-19 Survivors.
- Published in:
- Frontiers in Microbiology, 2021, v. 11, p. N.PAG, doi. 10.3389/fmicb.2021.661187
- By:
- Publication type:
- Article
Development of an Automated Chemiluminescence Assay System for Quantitative Measurement of Multiple Anti-SARS-CoV-2 Antibodies.
- Published in:
- Frontiers in Microbiology, 2021, v. 11, p. N.PAG, doi. 10.3389/fmicb.2020.628281
- By:
- Publication type:
- Article
Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0165609
- By:
- Publication type:
- Article
Prediction models for neutralization activity against emerging SARS-CoV-2 variants: A cross-sectional study.
- Published in:
- Frontiers in Microbiology, 2023, v. 14, p. 1, doi. 10.3389/fmicb.2023.1126527
- By:
- Publication type:
- Article
Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles.
- Published in:
- Journal of Molecular Cell Biology, 2020, v. 12, n. 12, p. 987, doi. 10.1093/jmcb/mjaa047
- By:
- Publication type:
- Article
Tissue factor pathway inhibitor-2 is specifically expressed in ovarian clear cell carcinoma tissues in the nucleus, cytoplasm and extracellular matrix.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1023, doi. 10.3892/or.2021.7944
- By:
- Publication type:
- Article
Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12827-0
- By:
- Publication type:
- Article